Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

152
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
152
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

390
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
390
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

SEMIPARAMETRIC ANALYSIS OF INTERVAL-CENSORED DATA SUBJECT TO INACCURATE DIAGNOSES WITH A TERMINAL EVENT.

The annals of applied statistics·2026
Same author

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

The annals of applied statistics·2026
Same author

Asymptotic Inference for Multi-Stage Stationary Treatment Policy with Variable Selection.

Journal of machine learning research : JMLR·2026
Same author

Data fusion methods for the heterogeneity of treatment effect and confounding function.

Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability·2026
Same author

Leveraging precision medicine analytics to optimize inflammation reduction and enhance physical function in older adults.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026

相关实验视频

Updated: Sep 15, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

为最佳的动态处理方案同时进行特征选择.

Mochuan Liu1, Yuanjia Wang2, Donglin Zeng3

  • 1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Statistics in medicine
|July 15, 2025
PubMed
概括
此摘要是机器生成的。

本研究介绍了动态治疗方案 (DTR) 的L1多阶段坡道损失 (L1-MRL) 学习. 该方法同时优化治疗决策,并在所有阶段选择相关特征,改进精准医学应用.

关键词:
决策能力 决策能力动态的治疗方案.拉索集团拉索是一个团队.悬崖损失功能 悬崖损失功能选择变量的选择变量.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

913

相关实验视频

Last Updated: Sep 15, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

913

科学领域:

  • 生物统计学 生物统计学
  • 机器学习 机器学习
  • 精准医学是一门精准的医学.

背景情况:

  • 动态治疗方案 (DTRs) 对于个性化医疗至关重要,随着时间的推移,根据患者的特征量身定制治疗.
  • 当前的DTR方法经常使用顺序方法,导致跨阶段的特征选择中累积错误.
  • 有效的特征选择对于开发节可靠的DTR至关重要.

研究的目的:

  • 为所有阶段同时优化DTR和特征选择开发一种新的框架.
  • 为了解决现有的顺序方法在处理多个决策点的功能重要性方面的局限性.
  • 为了提高学习最佳DTR的可靠性和实用性,在精准医学中.

主要方法:

  • 拟议的L1多阶段坡道损失 (L1-MRL) 学习框架,用于同时优化DTR和变量选择.
  • 利用单一的多阶段坡道损失函数来估计所有阶段的最佳DTR.
  • 实施了群体拉索类惩罚,用于识别任何阶段重要的特征.

主要成果:

  • 从理论上证明了拟议的L1-MRL估计器的一致性和预言性.
  • 模拟研究表明,L1-MRL的性能与现有的DTR方法相比或更好,具有变量选择.
  • 将该方法应用于2型糖尿病 (T2D) 患者的电子健康记录 (EHR) 数据.

结论:

  • L1-MRL学习提供了一种强大的方法,用于开发有效的DTR,同时进行特征选择.
  • 该方法克服了顺序方法的局限性,减少了虚假发现错误.
  • 这一框架通过使更可靠和节的治疗策略成为可能,推进了精准医学.